MedTrace Logo

Inhaled NO in Prevention of Chronic Lung Disease

NCT00000548 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2015-03-05

No results posted yet for this study

Summary

To test the hypothesis that low-dose inhaled nitric oxide administered to preterm infants who continue to require mechanical ventilation at 14 days of age will reduce the incidence of chronic lung disease.

Conditions

  • Bronchopulmonary Dysplasia
  • Lung Diseases

Interventions

PROCEDURE

mechanical ventilation

Sponsors & Collaborators

Principal Investigators

  • Roberta Ballard · Children's Hospital of Philadelphia

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE

Eligibility

Max Age
1 Year
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2000-03-31
Completion
2006-02-28

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00000548 on ClinicalTrials.gov